In order to determine the variation, we have compared the level of general breast cancer markers (MGB1, HER2) and genes used for CTCs-EBF classification into EMT phenotypes (CK19, CDH1, VIM, CDH2, PLS3). This evidence concerns the gene CDH2 and breast carcinoma.